English
Home > Products > CAS:853-23-6

China CAS:853-23-6 Manufacturer

We follow our enterprise spirit of "Quality, Efficiency, Innovation and Integrity". We aim to create much more worth for our buyers with our abundant resources, highly developed machinery, experienced workers and great providers for CAS:853-23-6,Prasterone Acetate,DHEA Acetate, We will continue to keep operating hard and as we consider our best to supply the most effective high-quality products, most competitive selling price and exceptional company to each customer. Your gratification, our glory!!!
CAS:853-23-6, Our company now has many department, and there have more than 20 employees in our company. We set up sales shop, show room, and product warehouse. In the meantime, we registered our own brand. Now we have tightened inspection for quality of product.

Related Products

Hot Products

  • Dutasteride

    Dutasteride

    Dutasteride has EP, USP, CP, IP, JP specification. CEP and FDA available.

    CAS:164656-23-9

  • Budesonide

    Budesonide

    Budesonide has USP, EP specifications. CEP, GMP and FDA approved.

    CAS:51333-22-3

  • Desonide

    Desonide

    Desonide has USP and EP specifications. DMF available.

    CAS:638-94-8

  • 6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy

    6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy

    6-chloro-1α-chloromethyl-3,20-dioxo-pregna-4,6-dien-17α-acetoxy is the intermediate of Cyproterone acetate.

    CAS:17183-98-1

  • Cariprazine hydrochloride

    Cariprazine hydrochloride

    Cariprazine hydrochloride has In-house specification. DMF approved.

    CAS:1083076-69-0

  • Epiandrosterone

    Epiandrosterone

    Epiandrosterone is a steroid hormone with weak androgenic activity. It is a metabolite of testosterone and dihydrotestosterone (DHT).

    CAS:481-29-8

  • Related Blog
  • Reviews

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • Gedian Humanwell successfully passed the EDQM audit

    The API -- cyproterone acetate, successfully passed the EU-GMP audit in April 2024.

  • Budesonide: A Great Product in the Treatment of Respiratory Ailments

    Please feel free to reach out to us for more information on product details.

  • What Are The Best Practices For Creating Intermediates Category Content

    For two decades at Google, my daily focus was unraveling how users search and what content truly satisfies their intent. One of the most persistent challenges I’ve seen businesses face is effectively presenting their specialized products, especially in technical niches. This is particularly true when crafting content for an Intermediates Category.

  • What Are Chemical Intermediates and How Are They Used in Pharmaceutical Manufacturing

    At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

  • Why Does an APIs Category Matter So Much When Choosing a Pharmaceutical Supplier?

    When buyers search for dependable pharmaceutical raw material partners, they often focus on price, lead time, and product availability first. In my experience, that approach can overlook a more important signal: how a supplier structures its APIs Category.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept